Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data. | J Cell Mol Med | 2021 | 33626208 | PubTator, text mining | PubMed |
| Alternative splicing and cancer: a systematic review. | Signal Transduct Target Ther | 2021 | 33623018 | PubTator, text mining | PubMed |
| KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation. | Nat Commun | 2021 | 33608534 | PubTator, text mining | PubMed |
| Identifying the degree of genetic interactions using Restricted Boltzmann Machine-A study on colorectal cancer. | IET Syst Biol | 2021 | 33590963 | PubTator, text mining | PubMed |
| Predicted 'wiring landscape' of Ras-effector interactions in 29 human tissues. | NPJ Syst Biol Appl | 2021 | 33580066 | PubTator, text mining | PubMed |
| New Insights into the Link between Melanoma and Thyroid Cancer: Role of Nucleocytoplasmic Trafficking. | Cells | 2021 | 33578751 | PubTator, text mining | PubMed |
| Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling. | Lung Cancer (Auckl) | 2021 | 33574724 | PubTator, text mining | PubMed |
| Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on. | Cancers (Basel) | 2021 | 33572755 | PubTator, text mining | PubMed |
| Post-Translational Modifications That Drive Prostate Cancer Progression. | Biomolecules | 2021 | 33572160 | PubTator, text mining | PubMed |
| The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis. | Genes Dis | 2021 | 33569513 | PubTator, text mining | PubMed |
| Mutant-selective degradation by BRAF-targeting PROTACs. | Nat Commun | 2021 | 33568647 | PubTator, text mining | PubMed |
| Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling. | Cancer Discov | 2021 | 33568355 | PubTator, text mining | PubMed |
| USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | J Biol Chem | 2021 | 33567341 | PubTator, text mining | PubMed |
| The Ins and Outs of RAS Effector Complexes. | Biomolecules | 2021 | 33562401 | PubTator, text mining | PubMed |
| Tumor and Systemic Immunomodulatory Effects of MEK Inhibition. | Curr Oncol Rep | 2021 | 33547983 | PubTator, text mining | PubMed |
| TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients. | Cancers (Basel) | 2021 | 33546249 | PubTator, text mining | PubMed |
| Arrayed CRISPR reveals genetic regulators of tau aggregation, autophagy and mitochondria in Alzheimer's disease model. | Sci Rep | 2021 | 33536571 | PubTator, text mining | PubMed |
| Whole-genome characterization of lung adenocarcinomas lacking the RTK/RAS/RAF pathway. | Cell Rep | 2021 | 33535033 | PubTator, text mining | PubMed |
| Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas. | Clin Cancer Res | 2021 | 33509808 | PubTator, text mining | PubMed |
| Next-generation sequencing for identification of actionable gene mutations in intestinal-type sinonasal adenocarcinoma. | Sci Rep | 2021 | 33500480 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=40